- Home
- FPI vs PLRX Comparison
FPI vs PLRX Comparison
Compare FPI & PLRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FPI
- PLRX
- Stock Information
- Founded
- FPI 2013
- PLRX 2015
- Country
- FPI United States
- PLRX United States
- Employees
- FPI N/A
- PLRX N/A
- Industry
- FPI Real Estate Investment Trusts
- PLRX Biotechnology: Pharmaceutical Preparations
- Sector
- FPI Real Estate
- PLRX Health Care
- Exchange
- FPI Nasdaq
- PLRX Nasdaq
- Market Cap
- FPI 607.9M
- PLRX 641.5M
- IPO Year
- FPI 2014
- PLRX 2020
- Fundamental
- Price
- FPI $11.39
- PLRX $11.77
- Analyst Decision
- FPI
- PLRX Strong Buy
- Analyst Count
- FPI 0
- PLRX 7
- Target Price
- FPI N/A
- PLRX $40.50
- AVG Volume (30 Days)
- FPI 430.7K
- PLRX 544.4K
- Earning Date
- FPI 02-26-2025
- PLRX 02-26-2025
- Dividend Yield
- FPI 2.10%
- PLRX N/A
- EPS Growth
- FPI N/A
- PLRX N/A
- EPS
- FPI 0.32
- PLRX N/A
- Revenue
- FPI $58,465,000.00
- PLRX N/A
- Revenue This Year
- FPI N/A
- PLRX N/A
- Revenue Next Year
- FPI N/A
- PLRX N/A
- P/E Ratio
- FPI $35.50
- PLRX N/A
- Revenue Growth
- FPI 1.30
- PLRX N/A
- 52 Week Low
- FPI $9.70
- PLRX $10.22
- 52 Week High
- FPI $12.85
- PLRX $18.92
- Technical
- Relative Strength Index (RSI)
- FPI 40.95
- PLRX 34.86
- Support Level
- FPI $11.54
- PLRX $12.40
- Resistance Level
- FPI $11.99
- PLRX $13.71
- Average True Range (ATR)
- FPI 0.26
- PLRX 0.76
- MACD
- FPI -0.04
- PLRX -0.17
- Stochastic Oscillator
- FPI 19.60
- PLRX 18.66
About FPI Farmland Partners Inc.
Farmland Partners Inc owns and seeks to acquire high-quality farmland throughout North America. The company is an internally managed real estate company which owns and contracts farmland and storage facilities located across the United States. Majority of the properties in its portfolio are used to grow primary crops, such as corn, soybeans, wheat, rice and cotton, and rest to produce specialty crops, such as almonds, citrus, blueberries, and vegetables. The company generates its revenues through the rent it receives from its tenants.
About PLRX Pliant Therapeutics Inc.
Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. Its primary product candidate is bexotegrast (PLN-74809), an oral, small molecule, that the company is developing for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis.